The NPM1 mutations in AML cases with a normal karyotype have been significantly associated with high frequency of internal tandem duplications of FMS-like tyrosine kinase-3 (FLT3/ITD) [1], which are considered to confer a less favorable prognosis. Here, NPM1 is linked to acute myeloid leukemia.